JP2020519895A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519895A5
JP2020519895A5 JP2019562415A JP2019562415A JP2020519895A5 JP 2020519895 A5 JP2020519895 A5 JP 2020519895A5 JP 2019562415 A JP2019562415 A JP 2019562415A JP 2019562415 A JP2019562415 A JP 2019562415A JP 2020519895 A5 JP2020519895 A5 JP 2020519895A5
Authority
JP
Japan
Prior art keywords
autoantibody
group
subject
autoantigen
autoantibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019562415A
Other languages
English (en)
Japanese (ja)
Other versions
JP7146286B2 (ja
JP2020519895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/032130 external-priority patent/WO2018209126A1/en
Publication of JP2020519895A publication Critical patent/JP2020519895A/ja
Publication of JP2020519895A5 publication Critical patent/JP2020519895A5/ja
Application granted granted Critical
Publication of JP7146286B2 publication Critical patent/JP7146286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019562415A 2017-05-10 2018-05-10 多発性硬化症の進行を検出する、サブタイプ分類する、および/または評価するための、診断用バイオマーカー Active JP7146286B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762504130P 2017-05-10 2017-05-10
US62/504,130 2017-05-10
PCT/US2018/032130 WO2018209126A1 (en) 2017-05-10 2018-05-10 Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis

Publications (3)

Publication Number Publication Date
JP2020519895A JP2020519895A (ja) 2020-07-02
JP2020519895A5 true JP2020519895A5 (cg-RX-API-DMAC7.html) 2021-07-26
JP7146286B2 JP7146286B2 (ja) 2022-10-04

Family

ID=64104996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019562415A Active JP7146286B2 (ja) 2017-05-10 2018-05-10 多発性硬化症の進行を検出する、サブタイプ分類する、および/または評価するための、診断用バイオマーカー

Country Status (5)

Country Link
US (3) US20210003570A1 (cg-RX-API-DMAC7.html)
EP (1) EP3622291A4 (cg-RX-API-DMAC7.html)
JP (1) JP7146286B2 (cg-RX-API-DMAC7.html)
CA (2) CA3304793A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018209126A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110186962B (zh) * 2019-05-10 2021-06-25 天津大学 一种用于电容层析成像的不完整测量数据成像方法
KR20230043181A (ko) * 2020-08-03 2023-03-30 프리베일 테라퓨틱스, 인크. 파킨을 코딩하는 aav 벡터 및 그의 용도

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5856092A (en) 1989-02-13 1999-01-05 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0604552B1 (en) 1991-09-18 1997-02-12 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers
DE69233087T2 (de) 1991-11-22 2003-12-24 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verfahren zur Herstellung von Polymerarrays
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5861242A (en) 1993-06-25 1999-01-19 Affymetrix, Inc. Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same
US6027880A (en) 1995-08-02 2000-02-22 Affymetrix, Inc. Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US6090555A (en) 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
EP0902885A4 (en) 1996-05-16 2006-09-27 Affymetrix Inc SYSTEMS AND METHODS FOR DETECTION OF BRANDED PRODUCTS
WO1998041657A1 (en) 1997-03-20 1998-09-24 Affymetrix, Inc. Iterative resequencing
US6201639B1 (en) 1998-03-20 2001-03-13 James W. Overbeck Wide field of view and high speed scanning microscopy
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US5936324A (en) 1998-03-30 1999-08-10 Genetic Microsystems Inc. Moving magnet scanner
US6218803B1 (en) 1999-06-04 2001-04-17 Genetic Microsystems, Inc. Position sensing with variable capacitance transducers
EP1345026B1 (en) 2002-03-15 2010-05-05 Affymetrix, Inc. System and method for scanning of biological materials
US20050032074A1 (en) 2002-09-09 2005-02-10 Affymetrix, Inc. Custom design method for resequencing arrays
US7300788B2 (en) 2002-10-08 2007-11-27 Affymetrix, Inc. Method for genotyping polymorphisms in humans
EP1561114B1 (en) 2002-11-07 2008-05-07 Erasmus Universiteit Rotterdam Fret probes and methods for detecting interacting molecules
US7317415B2 (en) 2003-08-08 2008-01-08 Affymetrix, Inc. System, method, and product for scanning of biological materials employing dual analog integrators
JP2013528799A (ja) 2010-05-13 2013-07-11 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 神経変性疾患の検知および診断のための診断用自己抗体プロファイル
WO2013010003A1 (en) 2011-07-12 2013-01-17 University Of Medicine And Dentistry Of New Jersey Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
US9746482B2 (en) 2011-08-11 2017-08-29 Rowan University Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease
WO2017180587A2 (en) * 2016-04-11 2017-10-19 Obsidian Therapeutics, Inc. Regulated biocircuit systems

Similar Documents

Publication Publication Date Title
Ghosh et al. Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
Kuijf et al. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA
AU2014224727B2 (en) Methods and compositions for the diagnosis of Alzheimer's disease
Fialová et al. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis
US10641780B2 (en) Methods and compositions for treatment of autoimmune hepatitis
JP5703314B2 (ja) 神経学的障害の予後判定のためのhmgb1および抗hmgb1抗体
JP4105156B2 (ja) 肝臓疾患用バイオマーカーおよびその使用方法
Bystrom et al. Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis
EP3655778B1 (en) Agrin as a marker for endometrial cancer
EP3987289A1 (en) Melanoma biomarkers
TWI598586B (zh) 川崎氏症之診斷與治療
EP3631456A1 (en) Method of detecting colitis ulcerosa
Zhang et al. Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma
EP3167286A1 (en) Autoantibody profiling in aps
Sun et al. Quantified CSF antibody reactivity against myelin in multiple sclerosis
JP2023533815A5 (cg-RX-API-DMAC7.html)
US20200018750A1 (en) Methods and compositions for the prediction and treatment of focal segmental glomerulosclerosis
Mejri et al. Spectrum of autoantibodies other than anti‐desmoglein in pemphigus patients
Uto et al. Clinical performance of three anti-dsDNA antibody immunoassays in systemic lupus erythematosus
EP2558856B1 (en) Method for diagnosis of multiple sclerosis involving anti-at1-receptor antibody
Reusz et al. Diagnosis and classification of hemolytic uremic syndrome: the Hungarian experience
US20130022987A1 (en) Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery
WO2025171422A1 (en) Method for diagnosing pancreatic ductal adenocarcinoma
WO2021024009A1 (en) Methods and compositions for providing colon cancer assessment using protein biomarkers
WO2017048857A2 (en) Methods of diagnosis and detection for steroidal drugs